Anti-retroviral reverse transcriptase inhibitor
|Each tablet contains: Didanosine 100 mg (buffered)|
Treatment of Human immunodeficiency virus in combination with other drugs.
Hypersensitivity, peripheral neuropathy, pancreatitis, liver disease, alcohol abuse, and renal failure.
Should be used only where there are compelling clinical indications. Nursing mothers: mothers taking Didanosine should not breast-feed their infants.
pancreatitis, lactic acidosis, severe hepatomegaly with steatosis, retinal changes and optic neuritis; and peripheral neuropathy;
|Adults:||> 60 kg: 200 mg twice daily.|
|< 60 kg: 125 mg twice daily.|
|Dosage adjustments are required in renal insufficiency.|
Tablets available as chewable buffered tablets.